317 related articles for article (PubMed ID: 15623773)
1. Decorin modulates wound healing in experimental glaucoma filtration surgery: a pilot study.
Grisanti S; Szurman P; Warga M; Kaczmarek R; Ziemssen F; Tatar O; Bartz-Schmidt KU
Invest Ophthalmol Vis Sci; 2005 Jan; 46(1):191-6. PubMed ID: 15623773
[TBL] [Abstract][Full Text] [Related]
2. Prolonged antiscarring effects of ilomastat and MMC after experimental glaucoma filtration surgery.
Wong TT; Mead AL; Khaw PT
Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):2018-22. PubMed ID: 15914618
[TBL] [Abstract][Full Text] [Related]
3. Modulation of postoperative scarring with tacrolimus and octreotide in experimental glaucoma filtration surgery.
Arslan S; Aydemir O; Güler M; Dağlı AF
Curr Eye Res; 2012 Mar; 37(3):228-33. PubMed ID: 22335810
[TBL] [Abstract][Full Text] [Related]
4. Effect of varying the mitomycin-C treatment area in glaucoma filtration surgery in the rabbit.
Cordeiro MF; Constable PH; Alexander RA; Bhattacharya SS; Khaw PT
Invest Ophthalmol Vis Sci; 1997 Jul; 38(8):1639-46. PubMed ID: 9224294
[TBL] [Abstract][Full Text] [Related]
5. Glaucoma filtration surgery using amniotic membrane transplantation.
Barton K; Budenz DL; Khaw PT; Tseng SC
Invest Ophthalmol Vis Sci; 2001 Jul; 42(8):1762-8. PubMed ID: 11431440
[TBL] [Abstract][Full Text] [Related]
6. Potential role of Rho-associated protein kinase inhibitor Y-27632 in glaucoma filtration surgery.
Honjo M; Tanihara H; Kameda T; Kawaji T; Yoshimura N; Araie M
Invest Ophthalmol Vis Sci; 2007 Dec; 48(12):5549-57. PubMed ID: 18055804
[TBL] [Abstract][Full Text] [Related]
7. Human anti-transforming growth factor-beta2 antibody: a new glaucoma anti-scarring agent.
Cordeiro MF; Gay JA; Khaw PT
Invest Ophthalmol Vis Sci; 1999 Sep; 40(10):2225-34. PubMed ID: 10476787
[TBL] [Abstract][Full Text] [Related]
8. Biocompatibility and antifibrotic effect of UV-cross-linked hyaluronate as a release-system for tranilast after trabeculectomy in a rabbit model--a pilot study.
Spitzer MS; Sat M; Schramm C; Schnichels S; Schultheiss M; Yoeruek E; Dzhelebov D; Szurman P
Curr Eye Res; 2012 Jun; 37(6):463-70. PubMed ID: 22577763
[TBL] [Abstract][Full Text] [Related]
9. Combined treatment with bevacizumab and 5-fluorouracil attenuates the postoperative scarring response after experimental glaucoma filtration surgery.
How A; Chua JL; Charlton A; Su R; Lim M; Kumar RS; Crowston JG; Wong TT
Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):928-32. PubMed ID: 19797222
[TBL] [Abstract][Full Text] [Related]
10. Postoperative use of bevacizumab as an antifibrotic agent in glaucoma filtration surgery in the rabbit.
Memarzadeh F; Varma R; Lin LT; Parikh JG; Dustin L; Alcaraz A; Eliott D
Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3233-7. PubMed ID: 19182254
[TBL] [Abstract][Full Text] [Related]
11. GGRGDSPCA peptide: a new antiscarring agent on glaucoma filtration surgery.
Avila M; Ortiz G; Lozano JM; Franco P; Patarroyo ME
Ophthalmic Surg Lasers; 2001; 32(2):134-9. PubMed ID: 11300635
[TBL] [Abstract][Full Text] [Related]
12. [The inhibitory effect of tissue plasminogen activator combined with 5-fluorouracil polyphase liposome on the scar formation in experimental filtration surgery].
Jing M; Xi S; Chen R
Zhonghua Yan Ke Za Zhi; 1997 Sep; 33(5):376-80. PubMed ID: 10451987
[TBL] [Abstract][Full Text] [Related]
13. The effect of paclitaxel on conjunctival wound healing: a pilot study.
Koz OG; Ozhuy S; Tezel GG; Karaman N; Unlu N; Yarangumeli A; Kural G
J Glaucoma; 2007; 16(7):610-5. PubMed ID: 18091179
[TBL] [Abstract][Full Text] [Related]
14. Novel antisense oligonucleotides targeting TGF-beta inhibit in vivo scarring and improve surgical outcome.
Cordeiro MF; Mead A; Ali RR; Alexander RA; Murray S; Chen C; York-Defalco C; Dean NM; Schultz GS; Khaw PT
Gene Ther; 2003 Jan; 10(1):59-71. PubMed ID: 12525838
[TBL] [Abstract][Full Text] [Related]
15. Decorin attenuates gliotic scar formation in the rat cerebral hemisphere.
Logan A; Baird A; Berry M
Exp Neurol; 1999 Oct; 159(2):504-10. PubMed ID: 10506521
[TBL] [Abstract][Full Text] [Related]
16. [Subconjunctival 5-fluorouracil polyphase liposome interference with scar formation in experimental filtration surgery].
Jing M; Xi S; Chen R
Zhonghua Yan Ke Za Zhi; 1996 Jan; 32(1):49-52. PubMed ID: 8758392
[TBL] [Abstract][Full Text] [Related]
17. CSM enhances the filtration bleb survival in rabbit model of experimental glaucoma surgery.
Ma J; Li X; Zhang W; Huang L; Chen M; Xi L; Zhang Z; Duan L; Quan D; Ge J
Curr Eye Res; 2014 Oct; 39(10):982-8. PubMed ID: 24787678
[TBL] [Abstract][Full Text] [Related]
18. Matrix metalloproteinase inhibition modulates postoperative scarring after experimental glaucoma filtration surgery.
Wong TT; Mead AL; Khaw PT
Invest Ophthalmol Vis Sci; 2003 Mar; 44(3):1097-103. PubMed ID: 12601035
[TBL] [Abstract][Full Text] [Related]
19. Effect of human RAD50 gene therapy on glaucoma filtering surgery in rabbit eye.
Yoon KC; Yang KJ; Seo JS; Lee SE; Heo T; Chun BJ; Jung S; Kim KK; Ahn KY
Curr Eye Res; 2004 Mar; 28(3):181-7. PubMed ID: 14977520
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of anti-TGF-beta2 antibody as a new postoperative anti-scarring agent in glaucoma surgery.
Mead AL; Wong TT; Cordeiro MF; Anderson IK; Khaw PT
Invest Ophthalmol Vis Sci; 2003 Aug; 44(8):3394-401. PubMed ID: 12882787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
